Equities

Arcoma AB

ARCOMA:STO

Arcoma AB

Actions
  • Price (SEK)13.10
  • Today's Change-0.20 / -1.50%
  • Shares traded87.22k
  • 1 Year change+73.51%
  • Beta0.8285
Data delayed at least 15 minutes, as of May 03 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).

  • Revenue in SEK (TTM)171.89m
  • Net income in SEK9.40m
  • Incorporated1990
  • Employees31.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nanexa AB29.33m-76.40m93.36m19.00--0.9742--3.18-0.9353-0.93530.41810.70620.1939-24.884.101,543,526.00-50.52-40.77-65.56-48.77201.72346.62-260.50-532.262.47--0.0404--925.42147.00-30.44--39.10--
Iconovo AB8.47m-42.40m94.05m29.00--0.947--11.10-3.68-3.680.7038.450.0554--1.24292,079.00-27.74-25.43-30.85-28.24234.21134.57-500.63-215.16----0.0666---58.65-9.884.71--34.70--
ScandiDos AB65.08m-4.85m98.06m34.00--2.27--1.51-0.1063-0.10631.430.75880.95730.47877.39---7.14-13.82-13.39-23.9582.5482.49-7.45-17.090.4511-2.630.00--6.704.01-24.27--4.18--
Episurf Medical AB11.10m-92.10m101.31m25.00--1.58--9.13-0.3449-0.34490.04160.24110.086--5.29396,428.60-71.42-47.46-81.48-52.01-----830.63-1,019.292.54--0.068--53.6219.78-22.64---0.4158--
Observe Medical ASA-99.45bn-99.45bn105.06m----0.4022----------1.38-----------31.10---51.60--33.76---274.820.0711--0.3526---18.80150.54-93.01--25.73--
BBS-Bioactive Bone Substitutes Oyj0.00-40.57m110.14m----1.76-----0.2926-0.29260.000.26470.00-------32.71-25.12-38.23-28.54-----------28.790.482-------12.64------
Redsense Medical AB (publ)24.97m-4.51m111.20m5.00--4.82--4.45-0.3214-0.32141.781.640.87248.186.324,993,400.00-15.77-18.66-17.96-20.9952.7069.02-18.08-46.283.49--0.00--74.1128.9448.47---23.62--
Ortivus AB84.08m-18.25m118.50m40.00--6.63--1.41-0.4118-0.41181.900.39060.9709--10.672,102,025.00-21.07-2.41-32.63-4.6336.6842.46-21.70-1.770.6327--0.2405---19.5510.00-409.66--67.43--
BibbInstruments AB0.00-10.97m122.04m----3.91-----0.4379-0.43790.001.180.00-------32.19-39.57-34.83-42.71--59.36---8,032.404.67----------2.72---1.94--
Clinical Laserthermia Systems AB8.27m-79.79m127.54m7.00--2.58--15.42-23.38-23.382.006.290.154310.954.20---150.84-123.49-292.98-312.95-508.29-1,084.16-977.58-1,625.031.50-5.240.0103--31.9935.55-12.92--18.61--
Dignitana AB86.06m-17.36m128.87m27.00--15.52--1.50-0.2464-0.24641.220.10311.664.3515.073,187,519.00-33.59-42.21-74.20-68.9168.5266.09-20.17-57.290.4633-6.820.7245--17.9020.5922.52---15.31--
Neola Medical AB0.00-9.01m132.58m7.00--1.68-----0.1616-0.16160.001.130.00----0.00-11.17-17.04-12.03-18.46--4,237.20---5,258.78----0.00------12.97--55.46--
Acousort AB5.54m-17.09m156.81m----6.48--28.33-1.23-1.230.40491.620.14575.102.52---44.97-48.62-79.33-69.77-69.83-68.05-308.76-299.582.76--0.00--11.5138.81-24.01------
Arcoma AB171.89m9.40m172.73m31.0018.373.2710.471.000.7130.71313.044.011.813.716.935,544,871.009.921.1218.492.0136.8337.665.470.75680.978811.950.04750.0030.366.4134.81--22.75--
Acarix AB6.24m-77.84m194.25m9.00--3.74--31.12-0.1642-0.16420.01320.07040.09430.15625.90---117.61-66.93-150.10-77.1284.8779.42-1,247.20-1,483.683.95-272.120.00--7.2043.55-1.11------
Nexstim Oyj84.38m-15.46m207.20m37.00--6.27--2.46-0.1956-0.19561.090.41920.72110.27083.76195,845.70-13.21-26.77-20.24-43.9096.3892.11-18.32-38.381.42-12.600.61---23.9422.08-201.58--19.51--
Data as of May 03 2024. Currency figures normalised to Arcoma AB's reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.